3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
1
Interventions
pembrolizumab
84
Specimen Handling
79
Carboplatin
74
Magnetic Resonance Spectroscopy
71
Biopsy
58
Nivolumab
55
Cisplatin
55
Paclitaxel
46
Cyclophosphamide
44
durvalumab
37
Radiotherapy
36
Radiation
35
Rituximab
34
olaparib
33
Etoposide
33
Dexamethasone
33
Ipilimumab
30
Gemcitabine
30
Lenalidomide
28
Taxes
27
Pemetrexed
27
Doxorubicin
27
Docetaxel
27
Bevacizumab
24
Prednisone
23
Cytarabine
23
X-Rays
22
Trastuzumab
21
cabozantinib
20
Disulfides
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Has results
×
Remote Patient Monitoring
×
Clear all
NCT04913259
2026-03-03
TS-PAC
Institut Bergonié
Phase NA
Active not recruiting
33 enrolled
8 charts